T cell response to 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in multiple sclerosis patients

Journal of Neuroimmunology

Volumn 130, Issue 1-2, 2002, Pages 233-242

  Muraro, P A ^a   Kalbus, M ^b   Afshar, G ^a   McFarland, H F ^a   Martin, R ^a  

^a National Institute of Neurological Disorders   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

2 ,3 Cyclic nucleotide 3 phosphodiesterase; Epitopes; Multiple sclerosis; Myelin proteins

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; EPITOPE; HLA DR2 ANTIGEN; HLA DR4 ANTIGEN; MYELIN PROTEIN;

ADULT; AMINO ACID SEQUENCE; ARTICLE; BLOOD DONOR; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENZYME ANALYSIS; FEMALE; HUMAN; IMMUNE RESPONSE; LYMPHOID CELL LINE; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE; TARGET CELL;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADULT; ANTIGENS, SURFACE; CD4-POSITIVE T-LYMPHOCYTES; CELL CULTURE TECHNIQUES; CELL DIVISION; CELLS, CULTURED; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MYELIN PROTEINS; PHENOTYPE; T-LYMPHOCYTES;

EID: 0036709641     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(02)00229-1     Document Type: Article

References (20)

1. Birnbaum G., Kotilinek L., Schlievert P., Clark H.B., Trotter J., Horvath E., Gao E., Cox M., Braun P.E. Heat shock proteins and experimental autoimmune encephalomyelitis (EAE): I. Immunization with a peptide of the myelin protein 2′,3′ cyclic nucleotide 3′ phosphodiesterase that is cross-reactive with a heat shock protein alters the course of EAE. J. Neurosci. Res. 44:1996;381-396.
2. Deibler G.E., Martenson R.E., Kies M.W. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep. Biochem. 2:1972;139-165.
3. Doyle H.A., Mamula M.J. Post-translational protein modifications in antigen recognition and autoimmunity. Trends Immunol. 22:2001;443-449.
4. Maatta J.A., Kaldman M.S., Sakoda S., Salmi A.A., Hinkkanen A.E. Encephalitogenicity of myelin-associated oligodendrocytic basic protein and 2′,3′-cyclic nucleotide 3′-phosphodiesterase for BALB/c and SJL mice. Immunology. 95:1998;383-388.
5. Mamula M.J., Gee R.J., Elliott J.I., Sette A., Southwood S., Jones P.-J., Blier P.R. Isoaspartyl post-translational modification triggers autoimmune response to self-proteins. J. Biol. Chem. 274:1999;22321-22327.
6. Martin R., McFarland H.F. Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis. Crit. Rev. Clin. Lab. Sci. 32(2):1995;121-182.
7. Martin R., Utz U., Coligan J.E., Richert J.R., Flerlage M., Robinson E., Stone R., Biddison W.E., McFarlin D.E., McFarland H.F. Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J. Immunol. 148:1992;1359-1366.
8. Morris-Downes M.M., McCormack K., Baker D., Sivaprasad D., Natkunarajah J., Amor S. Encephalitogenic and immunogenic potential of myelin-associated glycoprotein (MAG), oligodendrocyte-specific glycoprotein (OSP) and 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNPase) in ABH and SJL mice. J. Neuroimmunol. 122:2002;20-33.
9. Muraro P.A., Vergelli M., Kalbus M., Banks D., Nagle J.W., Tranquill L.R., Nepom G.T., Biddison W.E., McFarland H.F., Martin R. Immunodominance of a low-affinity MHC binding myelin basic protein epitope (residues 111-129) in HLA-DR4 (B1 * 0401) subjects is associated with a restricted T cell receptor repertoire. J. Clin. Invest. 100:1997;339-349.
10. Muraro P.A., Jacobsen M., Necker A., Nagle J.W., Gaber R., Sommer N., Martin R., Hemmer B. Rapid identification of local T cell expansion in inflammatory organ diseases by flow cytometric T cell receptor Vβ analysis. J. Immunol. Methods. 246:2000;131-143.
11. Peterson D.A., DiPaolo R.J., Kanagawa O., Unanue E.R. Quantitative analysis of the T cell repertoire that escapes negative selection. Immunity. 11:1999;453-462.
12. Pette M., Pette D.F., Muraro P.A., Farnon E., Martin R., McFarland H.F. Interferon β interferes with the proliferation but not with the cytokine secretion of MBP-specific, T helper type I lymphocytes. Neurology. 49:1997;385-392.
13. Riekkinen P.J., Rinne U.K., Arstila A.U., Kurihara T., Pelliniemi T.T. Studies on the pathogenesis of multiple sclerosis. 2′,3′-Cyclic nucleotide 3′-phosphohydrolase as marker of demyelination and correlation of findings with lysosomal changes. J. Neurol. Sci. 15:1972;113-120.
14. Rösener M., Muraro P.A., Riethmuller A., Kalbus M., Sappler G., Thompson R.J., Lichtenfels R., Sommer N., McFarland H.F., Martin R. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: a novel candidate autoantigen in demyelinating diseases. J. Neuroimmunol. 75:1997;28-34.
15. Sprinkle T.J. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit. Rev. Neurobiol. 4:1989;235-301.
16. Trotter J.L., Wegescheide C.L., Garvey W.F., Tourtellotte W.W. Studies of myelin proteins in multiple sclerosis brain tissue. Neurochem. Res. 9:1984;147-152.
17. Tsukada Y., Kurihara T. 2′,3′-Cyclic nucleotide 3′-phosphodiesterase: molecular characterization and possible functional significance. Martenson R.E. Myelin: Biology and Chemistry. 1992;448-480 CRC Press, Boca Raton, FL.
18. Viner N.J., Nelson C.A., Deck B., Unanue E.R. Complexes generated by the binding of free peptides to class II MHC molecules are antigenically diverse compared with those generated by intracellular processing. J. Immunol. 156:1996;2365-2368.
19. Walsh M.J., Murray J.M. Dual implication of 2′,3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J. Clin. Invest. 101:1998;1923-1931.
20. Ziegler K., Unanuè E.R. Identification of a macrophage antigen-processing event required for I region-restricted antigen presentation to T lymphocytes. J. Immunol. 127:1981;1869-1875.